Axsome Therapeutics, Inc. · 1 month ago
Associate Director/Director, Regulatory Affairs
Axsome Therapeutics is a biopharmaceutical company focused on treating CNS conditions. The Associate Director/Director, Regulatory Affairs will manage regulatory activities for product candidates and mentor associates, ensuring compliance and strategic development in regulatory submissions.
BiopharmaBiotechnologyTherapeutics
Responsibilities
Participate in regulatory agency interactions
Manage preparations for agency meetings, communications, and submissions
Author and review regulatory submissions including IND, NDA, and ex-US filings
Contribute to regulatory strategy development and planning
Assist and provide guidance for regulatory inspection readiness activities
Provides analysis of regulatory guidance documents and regulations to management team
Create, manage, measure, and report timelines for milestone deliverables
Participate in the development, review, and implementation of departmental SOPs, initiatives and processes
Additional responsibilities as assigned
Qualification
Required
Bachelor's degree required
7-10 years of relevant Regulatory Affairs experience
Proficiency in FDA electronic gateway submissions
Broad understanding of eCTD requirements
Willingness to travel as needed
Ability to work on site Monday, Tuesday & Thursday. We are unable to consider candidates who are looking for fully remote roles
Preferred
Preference for candidates with an scientific advanced scientific degree
Prior NDA and MAA filing experience
Prior CNS experience preferred but, not required
Experience in translating regulatory strategy into actionable plans
Established knowledge of regulatory guidelines and regulations (US and international)
Regulatory experience supporting both development projects and marketed products preferred
Knowledge of clinical research operations, including interpretation and implementation of FDA regulations/ICH/GCP guidelines, is preferred
Benefits
Annual bonus
Significant equity
Generous benefits package
Company
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc.
Funding
Current Stage
Public CompanyTotal Funding
$1B2025-05-13Post Ipo Debt· $570M
2023-06-28Post Ipo Equity· $225M
2019-12-23Post Ipo Equity· $200M
Recent News
2026-01-22
Clinical Trials Arena
2026-01-17
Company data provided by crunchbase